I feel like I have rarely seen an issue where so many people agree that we, just after the experience of COVID, learned in real time that certain supplies, certain issues, certain medical supplies and pharmaceuticals, at least a portion of them should be produced here, should be able to surge here.
Slotkin emphasizes the consensus on the need for domestic production of medical supplies post-COVID.
Share
More from Elissa Slotkin
(Trump’s) tariffs will squeeze our states’ small businesses and farmers harder and drive costs up for working families.
Our bill tackles this issue from every angle — awareness, outreach and access to care and testing — and I thank my colleagues from across the aisle as we all work to save lives.
Other voices in this conversation
